Resmed Inc
F:RME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Resmed Inc
F:RME
|
US |
|
O
|
Opawica Explorations Inc
OTC:OPWEF
|
CA |
|
W
|
Wilcon Depot Inc
XPHS:WLCON
|
PH |
|
S
|
Schlumberger NV
SIX:SLB
|
US |
|
I
|
InterDigital Inc
XBER:IDI
|
US |
Wall St Price Targets
RME Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for RME is 321.19 EUR with a low forecast of 211.53 EUR and a high forecast of 415.38 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RME's stock price target?
Price Target
321.19
EUR
According to Wall Street analysts, the average 1-year price target for RME is 321.19 EUR with a low forecast of 211.53 EUR and a high forecast of 415.38 EUR.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 4 years is 8%.
What is the Gross Profit forecast for Resmed Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 4 years is 10%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 4 years is 12%.
What is the Pre-Tax Income forecast for Resmed Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 4 years is 11%.
